First Nebraska Trust’s CME Group CME Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $577K | Sell |
1,955
-36
| -2% | -$10.7K | 0.05% | 132 |
|
|
2025
Q4 | $544K | Buy |
1,991
+36
| +2% | +$9.78K | 0.05% | 132 |
|
|
2025
Q3 | $528K | Hold |
1,955
| – | – | 0.05% | 128 |
|
|
2025
Q2 | $539K | Hold |
1,955
| – | – | 0.05% | 122 |
|
|
2025
Q1 | $519K | Hold |
1,955
| – | – | 0.05% | 120 |
|
|
2024
Q4 | $454K | Hold |
1,955
| – | – | 0.04% | 131 |
|
|
2024
Q3 | $431K | Hold |
1,955
| – | – | 0.04% | 132 |
|
|
2024
Q2 | $384K | Hold |
1,955
| – | – | 0.04% | 138 |
|
|
2024
Q1 | $421K | Hold |
1,955
| – | – | 0.04% | 129 |
|
|
2023
Q4 | $412K | Hold |
1,955
| – | – | 0.05% | 129 |
|
|
2023
Q3 | $391K | Buy |
1,955
+120
| +7% | +$23.9K | 0.05% | 124 |
|
|
2023
Q2 | $340K | Hold |
1,835
| – | – | 0.04% | 130 |
|
|
2023
Q1 | $351K | Hold |
1,835
| – | – | 0.04% | 126 |
|
|
2022
Q4 | $309K | Hold |
1,835
| – | – | 0.04% | 136 |
|
|
2022
Q3 | $325K | Hold |
1,835
| – | – | 0.05% | 123 |
|
|
2022
Q2 | $376K | Sell |
1,835
-165
| -8% | -$35K | 0.05% | 120 |
|
|
2022
Q1 | $476K | Hold |
2,000
| – | – | 0.06% | 116 |
|
|
2021
Q4 | $457K | Hold |
2,000
| – | – | 0.06% | 119 |
|
|
2021
Q3 | $387K | Hold |
2,000
| – | – | 0.05% | 121 |
|
|
2021
Q2 | $425K | Hold |
2,000
| – | – | 0.06% | 117 |
|
|
2021
Q1 | $408K | Hold |
2,000
| – | – | 0.05% | 114 |
|
|
2020
Q4 | $364K | Hold |
2,000
| – | – | 0.05% | 116 |
|
|
2020
Q3 | $335K | Hold |
2,000
| – | – | 0.06% | 115 |
|
|
2020
Q2 | $325K | Hold |
2,000
| – | – | 0.06% | 117 |
|
|
2020
Q1 | $346K | Hold |
2,000
| – | – | 0.08% | 106 |
|
|
2019
Q4 | $401K | Hold |
2,000
| – | – | 0.07% | 101 |
|
|
2019
Q3 | $423K | Hold |
2,000
| – | – | 0.07% | 99 |
|
|
2019
Q2 | $388K | Sell |
2,000
-225
| -10% | -$41.5K | 0.07% | 101 |
|
|
2019
Q1 | $366K | Hold |
2,225
| – | – | 0.07% | 104 |
|
|
2018
Q4 | $419K | Hold |
2,225
| – | – | 0.09% | 92 |
|
|
2018
Q3 | $379K | Hold |
2,225
| – | – | 0.06% | 96 |
|
|
2018
Q2 | $365K | Hold |
2,225
| – | – | 0.08% | 98 |
|
|
2018
Q1 | $360K | Hold |
2,225
| – | – | 0.07% | 99 |
|
|
2017
Q4 | $325K | Hold |
2,225
| – | – | 0.07% | 102 |
|
|
2017
Q3 | $302K | Buy |
2,225
+100
| +5% | +$12.6K | 0.07% | 105 |
|
|
2017
Q2 | $266K | Buy |
+2,125
| New | +$254K | 0.06% | 113 |
|
Other funds holding CME
VCM
VPM
First Nebraska Trust's CME Position: Q1 2026 in Review
First Nebraska Trust reduced its CME Group (CME) stake by 1.8% in Q1 2026, selling an estimated $10.7K and leaving 1,955 shares worth $577K. The position accounts for 0.05% of the portfolio, ranked #132.
First Nebraska Trust first reported a position in CME in Q2 2017 and has held it in 36 quarters since. 1,790 funds tracked by Wall St. Rank hold CME as of Q1 2026.
- First Nebraska Trust held 1,955 shares of CME Group worth $577K as of Q1 2026.
- First Nebraska Trust sold 36 CME Group shares in Q1 2026, an estimated $10.7K.
- CME Group made up 0.05% of First Nebraska Trust's portfolio in Q1 2026, its #132 holding.
- First Nebraska Trust first reported a position in CME Group in Q2 2017 and has held it in 36 quarters since.
- 1,790 funds tracked by Wall St. Rank held CME Group as of Q1 2026.
Based on First Nebraska Trust's 13F filing for Q1 2026, filed 1 Jun 2026.